- Home
- MS vs NVS Comparison
MS vs NVS Comparison
Compare MS & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MS
- NVS
- Stock Information
- Founded
- MS 1924
- NVS 1895
- Country
- MS United States
- NVS Switzerland
- Employees
- MS N/A
- NVS N/A
- Industry
- MS Investment Bankers/Brokers/Service
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- MS Finance
- NVS Health Care
- Exchange
- MS Nasdaq
- NVS Nasdaq
- Market Cap
- MS 255.6B
- NVS 248.3B
- IPO Year
- MS N/A
- NVS 1991
- Fundamental
- Price
- MS $157.56
- NVS $132.42
- Analyst Decision
- MS Buy
- NVS Sell
- Analyst Count
- MS 13
- NVS 4
- Target Price
- MS $149.92
- NVS $119.00
- AVG Volume (30 Days)
- MS 5.7M
- NVS 1.3M
- Earning Date
- MS 10-15-2025
- NVS 10-28-2025
- Dividend Yield
- MS 2.54%
- NVS 1.96%
- EPS Growth
- MS 45.57
- NVS N/A
- EPS
- MS 8.83
- NVS 6.85
- Revenue
- MS $65,612,000,000.00
- NVS $55,186,000,000.00
- Revenue This Year
- MS $12.62
- NVS $8.96
- Revenue Next Year
- MS $4.55
- NVS $2.52
- P/E Ratio
- MS $17.85
- NVS $18.76
- Revenue Growth
- MS 16.92
- NVS 12.95
- 52 Week Low
- MS $94.33
- NVS $96.06
- 52 Week High
- MS $163.98
- NVS $133.37
- Technical
- Relative Strength Index (RSI)
- MS 56.31
- NVS 70.59
- Support Level
- MS $153.71
- NVS $122.21
- Resistance Level
- MS $162.23
- NVS $131.96
- Average True Range (ATR)
- MS 2.95
- NVS 1.51
- MACD
- MS -0.69
- NVS 0.87
- Stochastic Oscillator
- MS 37.44
- NVS 91.95
About MS Morgan Stanley
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the great financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.